What You Should Know:
Today, OM1 announced the launch of its Parkinson’s Disease datasets, enhancing its Mental Health & Neuroscience Real-World Data Network.OM1’s Mental Health & Neuroscience Real-World Data Network, which already includes robust datasets focused on Major Depressive Disorder, Multiple Sclerosis, Bipolar Disorder I and Schizophrenia, will further expand to include Alzheimer’s Disease in the coming months.
Parkinson’s Disease Premium Dataset
Nearly
Read More
OM1
OM1 Launches AI-Powered Digital Phenotypes Platform, Creating “Fingerprints” for Patients
What You Should Know:
OM1, a real-world data, outcomes and technology company with a focus on chronic conditions, launches PhenOM™, its artificial intelligence-powered platform for personalized medicine.
Calibrated using OM1’s longitudinal health history datasets, PhenOM uses AI to identify unique digital phenotypes associated with conditions and outcomes and compare patients’ records to them to highlight risks and opportunities. PhenOM powers personalized healthcare insights at scale
Read More
OM1 Raises $15M to Expand Healthcare Outcome Analytics Platform
OM1(formerly known as Better Outcomes), a Boston, MA-based healthcare outcome analytics company has raised $15M in Series A funding led by General Catalyst with participation from Glikvest, 7wire Ventures and Wanxiang Healthcare Investments. The company plans to utilize the funding to build out its tech platform that leverages big data and artificial intelligence (AI) to provide stakeholders with an analytics platform to have a holistic view and better understanding of real-world healthcare
Read More
